The University of Chicago Header Logo

Connection

Mark J. Ratain to Dipeptides

Back to Details
This is a "connection" page, showing publications Mark J. Ratain has written about Dipeptides.
Mark J. Ratain
Connection Strength
0.252
Dipeptides
  1. Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors. Invest New Drugs. 2004 Nov; 22(4):449-58.
    View in: PubMed
    Score: 0.252
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.